Genomics stories
Access to Google Cloud's code-optimisation agent now expands after early tests showed gains in forecasting, routing, chip design and research.
Researchers can now analyse data, search literature and draft papers in one place, with outputs kept reproducible on their own infrastructure.
Pharmaceutical researchers could speed up discovery workflows as Anthropic's new Claude Science beta gains access to NVIDIA's BioNeMo tools.
Data centres and research labs could cram larger AI models and simulations in memory, with Dell's new rack scaling to 144 GPUs per rack.
The rack-ready system targets organisations needing denser, liquid-cooled infrastructure as AI and scientific computing demands surge.
Many harmless prompts will now be diverted to Claude Opus 4.8 as Anthropic tightens safeguards around its newest general-use model.
Users can now route AI and HPC jobs across five clouds and on-premises through one workflow, cutting rebuilds and manual reconfiguration.
Eligible research organisations can now access OpenAI's updated GPT-Rosalind model, as the company widens its life sciences rollout worldwide.
Enterprises seeking decades-long retention may soon get a DNA archive tier managed within familiar object storage systems, pending integration work.
The update lets AI and HPC teams move workloads across five clouds and on-premises, cutting duplication and simplifying GPU access.
Researchers will gain tools to cut literature review and modelling time as Google opens access to experimental Gemini for Science features gradually.
Rising US and Asia-Pacific demand lifted first-quarter revenue 22% at SOPHiA GENETICS, as genomic analyses hit a record 108,000.
Research teams could see faster target discovery as OpenAI opens GPT-Rosalind to qualified US customers for biology and drug discovery work.
The Danish quantum software firm is pushing into life sciences now, adding senior hires and partners to sell hybrid tools before the market matures.
The move gives the campus its first commercial occupier for The Sequence and adds 21,000 sq ft of labs for health start-ups.
AI use is spreading across Canadian business, with AWS Canada saying 65% now use it, mostly for routine workflow and content tasks.
The advisory body is meant to steer an expanded Cambridge site aiming to house 9,000 people and about 250 life sciences companies by 2028.
Leaders said earlier diagnosis, data reform and community care could ease NHS pressure if the service is to shift towards prevention by 2035.
Information on about 500,000 volunteers is being offered for sale online, raising fears that stolen health and DNA data could be misused for years.
The London biotech startup will use new funding to broaden deployments at major drugmakers, including Pfizer, and speed research decisions.
.webp)
